Synapse - Works

Results (5611)

Phase Ib of copanlisib in combination with ibrutinib in recurrent/refractory primary CNS lymphoma (PCNSL)

Meeting Abstract

Grommes, C.; Gavrilovic, I.; Miller, A. M.; Stone, J. B.; Kaley, T.; Madzsar, J. T.; Schumpp, A.; Butler, B. T.; Schaff, L.; Mellinghoff, I. K.
Blood (2019)

Fulltext@MSK | Save

Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory children and young adults with acute lymphoblastic leukemia (ALL): Real world experience from the Center for International Blood and Marrow Transplant Research (CIBMTR) and cellular therapy (CT) registry

Meeting Abstract

Grupp, S.; Hu, Z. H.; Zhang, Y.; Keating, A.; Pulsipher, M. A.; Philips, C.; Margossian, S. P.; Rosenthal, J.; Salzberg, D.; Schiff, D. E.; more...
Blood (2019)

Fulltext@MSK | Save

Re-induction and targeted conditioning with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] leads to high rates of transplantation and successful engraftment in older patients with active, relapsed or refractory (rel/ref) AML after failure of chemotherapy and targeted agents: Preliminary midpoint results from the prospective, randomized phase 3 Sierra Trial

Meeting Abstract

Gyurkocza, B.; Nath, R.; Stiff, P. J.; Agura, E.; Litzow, M.; Tomlinson, B.; Choe, H. K.; Abhyankar, S.; Seropian, S.; Chen, G. L.; more...
Blood (2019)

Fulltext@MSK | Save

Effect of active hepatitis C infection in relapse-free survival among patients with HIV-related diffuse large B-cell lymphoma

Meeting Abstract

Gonzalez-Lugo, J. D.; Acuna-Villaorduna, A.; Shah, U. A.; Friedman, E. W.
Blood (2019)

Fulltext@MSK | Save

Cardiovascular (CV)-related hospitalizations and associated costs among US patients in simplicity: An observational study of patients with chronic-phase chronic myeloid leukemia (CP-CML) in routine clinical practice

Meeting Abstract

Goldberg, S. L.; Mauro, M. J.; Cortes, J. E.; Keating, S. J.; Bhandari, H.; Chen, C.
Blood (2019)

Fulltext@MSK | Save

Management of CAR T-cell toxicities: Concordance and divergence between healthcare providers and expert consensus recommendations

Meeting Abstract

Frigault, M.; Cartwright, M.; Marcello, K.; Quill, T. A.; DeAngelo, D. J.; Galinsky, I.; Paul, S.; Park, J. H.
Blood (2019)

Fulltext@MSK | Save

Results of the phase 3 VITAL study of NEOD001 (birtamimab) plus standard of care in patients with light chain (AL) amyloidosis suggest survival benefit for Mayo stage IV patients

Meeting Abstract

Gertz, M. A.; Cohen, A. D.; Comenzo, R. L.; Du Mond, C.; Kastritis, E.; Landau, H. J.; Libby, E. N. 3rd; Liedtke, M.; Merlini, G.; Sanchorawala, V.; more...
Blood (2019)

Fulltext@MSK | Save

Incidence of delayed seromas and related risk of BIA-ALCL in a cohort of 3521 breast cancer women with textured implants prospectively followed long term

Meeting Abstract

Ghione, P.; Cordeiro, P.; Seshan, V.; Galasso, N.; Ganesan, N.; Hu, Q.; Dogan, A.; Horwitz, S. M.
Blood (2019)

Fulltext@MSK | Save

Lactate dehydrogenase is a key prognostic factor in acute myeloid leukemia and lymphoma patients undergoing allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Geva, M.; Shouval, R.; Fein, J. A.; Danylesko, I.; Shem-Tov, N.; Yerushalmi, R.; Shimoni, A.; Nagler, A.
Blood (2019)

Fulltext@MSK | Save

Younger patients with newly diagnosed FLT3-mutant AML treated with crenolanib plus chemotherapy achieve adequate free crenolanib levels and durable remissions

Meeting Abstract

Goldberg, A. D.; Coombs, C. C.; Wang, E. S.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Messahel, B.; Stone, R. M.; Collins, R. H.
Blood (2019)

Fulltext@MSK | Save